English | 中文版



Beijing Zero Zero Technology Co.,Ltd (ZZ) is a world-class robotics company pioneering the future of artificial intelligence (AI) smart equipment, machine vision, and high-precision control solutions. The founder and CEO, Mengqiu Wang, graduated with a PhD in Computer Science from Stanford University focusing on the domain of artificial intelligence. The company was awarded first place in “Maker World 2015: The Overseas Experts Innovation and Entrepreneurship Competition", which garnered the company plenty of media focus and support from the governments of Zhejiang and Hangzhou provinces. This accomplishment became a central focus to interviews of continued news coverage. On April 28th 2016, the company’s first product, a self-flying drone camera was presented at the Beijing Global Mobile Internet Conference.



CHINT New Energy Development (Zhejiang) Co., Ltd, as the largest Photovoltaic power company in China, is the subsidiary of CHINT Group with professionalism of investment, construction, operation and outsourcing in solar park industries.



mProbe, established by the director of the Stanford University Medical Center, is a leading global company based on Multi-omics analysis and its applications on precision medicine and health management. It is plan to set up the R&D and operations centers both in Silicon Valley and Tianjin, China. mProbe focuses on defining medical parameters and detecting disease using mass spectrometers and computer models, which is expected to challenge traditional medical detection method, reduce testing costs, improve overall accuracy, and detect disease in the early stage to create overall well-being.

Yueer Media

Yueer Media(838697) is a modern media company devoted to business news entertainment and integrated media coverage. Its business model consists of providing high quality business news and integrating business community operations and offline marketing services to high net worth individuals and families.

Zhehua SummitView Fund

Zhehua SummitView fund makes full use of the strengths of Yangtze Delta Region Institute of Tsinghua University, Zhejiang, in scientific research and technology, combining with the industrial resources of ZUIG and professional investment experience of ZUIG and SummitView Capital, to support the development of new technologies as well as the growing technology firms. In addition, the fund is actively involved in technology innovation and advanced business models, so as to fulfill social service commitment to propel upgrade of the key industries in Zhejiang and contribute to its economic development.

GP Medical Service Fund

GP Healthcare Service Capital (GP HS Capital) mainly focuses on investment opportunities in China’s healthcare and medical service sector. It is one of the seven sub-funds of GP Capital Fund II and founded based on the success of GP Capital Fund I, which managed Shanghai Financial Development Investment Fund since 2011. ZUIG and GP HS Capital cooperate with each other on the Fund II, and will seek attractive opportunities in hospital chains, as well as medical technology, medical device and medical logistics areas.
GP HS Capital’s LP include Chongqing Municipal’ PPP Fund, Shanghai Municipal Investment Corporation, USUM Investment Group, Shagang Group, Chongqing Linkong Investment Group, SHINVA(600587.SH), and KN Hospital (2120.HK). Shanghai Fudan Healthcare Investment Company and Health 100 are also GP HS Fund’s strategic partners.



ULSee, founded in August 2014, provides turn-key solutions in AR/VR domains based on the best-in-class face tracking, 3D modeling, and face recognition technologies developed by itself. The company is revolutionizing the way humans and computers interact, especially in the field of social media and entertainment, and will further apply its core technologies to virtual shopping, financial payment and safe driving, so as to lead the next generation of artificial intelligence and computer vision technologies.



Jinjiang Environment Holding Company Limited (SGX:BWM) is the first private WTE operator in China and continue to be the leading WTE operator in the PRC with the largest waste treatment capacity in operation. The company has accumulated 18 years of operational experience, developed a suite of WTE technologies specifically adapted to various types of municipal solid waste, and continue to maintain a leading position for CFB technology for WTE .China Jinjiang Environment (Jinjiang Environment) listed on the Mainboard of Singapore Exchange (SGX) on 3rd August ,2016.

Zhejiang Bang’er Medical Investment

Zhejiang Bang’er Medical Investment (“Bang’er Orthopedics”) is a leading Chinese private orthopedic hospital operator in the Yangtze River Delta Region. Enjoying strategic alliance with renowned US institutions such as Fidelity Growth Partners, PreferUS Healthcare and Genesis Rehab Services (NYSE: GEN), Bang’er Orthopedics, with its footprint of 11 specialty hospitals totaling 2,500 beds, specializes in trauma surgery and postoperative rehabilitation across Zhejiang, Jiangsu and Anhui Province. Performing over 20,000 surgeries annually, Bang’er Orthopedics is well positioned to transform from a regional player to national leader in the Chinese orthopedic healthcare market.



LinkonWorks (‘Ling Kang’) provides management solutions for chronic diseases to healthcare institutions and services to pharmacy supply chain. Drawing on the proprietary software platform and pharmacy automation technology, LinkonWorks is currently piloting a chronic diseases program to increase patients' compliance and to cut healthcare costs.

China UMS

China UMS, controlled by China UnionPay, is a leading integrated bank card payment service provider in China. China UMS was founded in 2003 and is focusing on POS business, MIS-POS business, Internet payment business, mobile payment business, ATM operation business and etc. China UMS maintains the largest market share in traditional bank card payment business and ranks the third in the Internet payment business. According to Nielsen report, China UMS was the largest card payment service company in the Asia-Pacific region in 2014 in terms of the transaction volume and size. By October 2016, China UMS has set up agencies across China, covering over 337 cities, 6.31 million merchants and 7.86 million POS terminals.


Shenzhen XiangFenghua Technologies Inc

Shenzhen XiangFenghua Technologies Inc, founded in June 2009, is a company producing high-end Cathode material for lithium ion battery. The company owns a number of invention patents, which prove its leading industry position. XiangFenghua has strong R & D, production and sales teams from Tsinghua University, Chinese Academy of Sciences and other well-known institutes. With rich experiences in the green energy industry, the company has established advanced production quality management system and the automatic production lines. The company cooperates with Tsinghua University, Chongqing University, Central South University and etc. Xiangfenghua has a full product line, covering the natural graphite, artificial graphite, composite graphite, silicon carbon, titanium, graphene and etc. The company's products are widely used for electric vehicles, electric bicycles, power plants and 3C digital products.



AUPU, founded in 1993, is the founder and leader of China bathroom electrical industry, with the largest production base of sanitary products in Asia. AUPU has made more than 150 national patents, through a number of international safety certification, and has won "China Top 500", "China Small Appliances Original Award", "China Home Appliances Technology Innovation Award", "China Green Star "and many other honors. AUPU has more than 1,000 brand stores and 5,000 sale terminals in the country.



In Sep. 2003, Keboda was established in Shanghai Zhangjiang High-tech Park. The headquarter is located in Pudong New district, Shanghai with 5 wholly-owned subsidiaries in Jiaxing, Chongqing, Wenzhou,and other places, and 2 Sino-Chinese Joint ventures with a German and an Austrian company. Keboda is certified as the national key high-tech enterprise. Keboda focuses on the development and manufacturing of automotive electronics for the global automotive industry, benefitted by our innovative research and development capability. Keboda became fully integrated into the global automotive industry value chain, and participated in the global competition of high-end market. We are the development partner and the key supplier for many global car makers such as Audi, VW, Chrysler, Citroen, Mercedes Benz, Porsche, Ford, Cummins, etc. gaining honor for the term “Invented in China”.


Zhenxing Biopharmaceutical & Chemical Co., Ltd.

Zhenxing Biopharmaceutical & Chemical Co., Ltd. (“Zhenxing Bio&Chem”), a high-tech listed company trading at Shenzhen Stock Exchange (SZSE:000403), is principally engaged in the research and development, manufacturing and sales of plasma products through Its main business entity, Guangdong Shuanglin Bio-pharmacy Co., Ltd. With 21 individual blood collection stations producing 400 tons of plasma annually, the company is expected to realize more growth potential in the future. The current products of the company have been categorized into 2 broad classifications and 6 product segmentations. With a tender offer made in December, 2017, Zhejiang United Investment Group (“ZUIG”) has successfully become the first largest shareholder of Zhenxing Bio&Chem. The transaction has been seen as a milestone in the history of Chinese securities market. ZUIG is going to concentrate on the plasma industry chain, develop the upstream and downstream of the industry, and achieve greater success.

Zhejiang SilkRoad Fund

Zhejiang SilkRoad Fund is a major overseas investment platform in Zhejiang Province with initial fund size of CNY 5 billion. The main sponsor is Zhejiang United Investment Group (“ZUIG”), drawing on the guidance and support from Department of Commerce of Zhejiang Province, co-invested by leading private enterprises, state-owned enterprises, state-owned banks, and government sponsored industrial funds. Zhejiang SilkRoad Fund adheres to the principles of “market-oriented operations with government support”, and able to integrate the global investment resources to the maximum extent to build a comprehensive international investment platform. Key investment strategies include but not limited to joint acquisition, direct investment, and parallel investment.


FR Capital

Zhejiang Qiantangjiang Financial Research Asset Management Co., Ltd. (FR Capital) fully leverages the resources of Zhejiang Qiantangjiang Institute of Financial Research, large financial institutions and listed companies. FR Capital focuses its investments in 6 fields, including TMT, high-end equipment & intelligent manufacturing, energy saving & environmental friendly industry, health care, education and consumer goods. It maintains collaborative relationships with top professional institutions from USA, Germany and France. FR Capital is the registered PE fund manager of Asset Management Association of China, Vice Chairman of China Venture Capital & Private Equity Association and member of Institute of International Finance.The main businesses of FR Capital are asset management, investment banking and cross-border two-way investment. Current portfolio includes Soft Stone, ExSpace, Gooday, Pioneer Operation, Montage Technology, Power New Energy, etc.

Home | About ZUIG | Our team | Portfolio | Investment strategy | Media center | Contact us